The new study says 'yes' – but we will...
p-value
Virafin's phase 2 trial has several methodological and reporting...
The researchers who conducted the inadequate trial on itolizumab...
The story behind the premature hype of hydroxychloroquine involves...
In a special issue of its quarterly publication, the...
The case against p-values and statistical significance is not...











